Compound information
- Natural Products
- ZC1585000
- Molecular Formula
- C16H23BrN2O5S
- Molecular Weight
- 434.051104936 g/mol
- Structure
-
- IUPAC Name
- tert-butyl 4-(3-bromo-4-methoxy-phenyl)sulfonylpiperazine-1-carboxylate
- InChI
- InChI=1S/C16H23BrN2O5S/c1-16(2,3)24-15(20)18-7-9-19(10-8-18)25(21,22)12-5-6-14(23-4)13(17)11-12/h5-6,11H,7-10H2,1-4H3
- InChI Key
- JHNVNOGLOUZHRL-UHFFFAOYSA-N
- SMILES
- COc1ccc(S(=O)(=O)N2CCN(C(=O)OC(C)(C)C)CC2)cc1Br
- Source
- ZINC000105436244
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 25 | Ring Count | 2 |
Heteroatom Count | 9 | Rotatable Bond Count | 3 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 76.15 Å2 | LogP | 3.028 |
LogS | -4.45 | LogD | 3.598 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.063 | Pgp substrate | 0.013 |
HIA | 0.968 | F20 % | 0.962 |
F30 % | 0.944 | Caco-2 | -4.634 |
MDCK | -4.881 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.87 | PPB | 97.136 |
VD | 2.298 | Fu | 0.6 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.466 | CYP1A2 substrate | 0.456 |
CYP2A6 substrate | 0.571 | CYP2B6 substrate | 0.639 |
CYP2C19 inhibitor | 0.96 | CYP2C19 substrate | 0.73 |
CYP2C8 substrate | 0.651 | CYP2C9 inhibitor | 0.419 |
CYP2C9 substrate | 0.998 | CYP2D6 inhibitor | 0.018 |
CYP2D6 substrate | 0.655 | CYP2E1 substrate | 0.763 |
CYP3A4 inhibitor | 0.171 | CYP3A4 substrate | 0.999 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.403 | CL | 6.575 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.532 | Hepatotoxicity | 0.997 |
Mutagenicity | 0.66 | Rat Oral Acute Toxicity | 0.22 |
FDAMDD | 0.072 | Skin Sensitization | 0.002 |
Carcinogenicity | 0.884 | Eye Corrosion | 0.01 |
Eye Irritation | 0.008 | Respiratory Toxicity | 0.795 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.565 | IGC50 | 4.262 |
LC50FM | 2.567 | LC50DM | 3.494 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.367 | NR-AR-LBD | 0.288 |
NR-AhR | 0.042 | NR-Aromatase | 0.246 |
NR-ER | 0.27 | NR-ER-LBD | 0.43 |
NR-PPAR-gamma | 0.118 | SR-ARE | 0.691 |
SR-ATAD5 | 0.384 | SR-HSE | 0.078 |
SR-MMP | 0.052 | SR-p53 | 0.033 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.